Squarepoint
ONCE

Squarepoint’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Squarepoint’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-28,618
Closed -$1.12M – 2574
2018
Q4 		$1.12M Sell
28,618
-36,648
-56% -$1.59M 0.01% 878
2018
Q3 		$3.56M Buy
+65,266
New +$4.46M 0.04% 501
2018
Q2 		– Sell
-17,500
Closed -$1.17M – 2203
2018
Q1 		$1.17M Buy
+17,500
New +$1.01M 0.02% 740
2017
Q4 		– Sell
-4,161
Closed -$371K – 2453
2017
Q3 		$371K Buy
+4,161
New +$316K 0.01% 1082
2017
Q2 		– Sell
-9,151
Closed -$488K – 1952
2017
Q1 		$488K Buy
+9,151
New +$543K 0.01% 866
2016
Q1 		– Sell
-10,400
Closed -$471K – 1573
2015
Q4 		$471K Buy
+10,400
New +$545K 0.05% 568

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Squarepoint's ONCE Position: Q1 2019 in Review

Squarepoint sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 28,618 shares — an estimated $1.12M sold.

Squarepoint first reported a position in ONCE in Q4 2015 and held it in 6 quarters. The position peaked at $3.56M in Q3 2018. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • Squarepoint reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Squarepoint sold 28,618 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $1.12M.
  • Squarepoint first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 6 quarters.
  • Squarepoint's Spark Therapeutics, Inc. Common Stock position peaked at $3.56M in Q3 2018.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Squarepoint's 13F filing for Q1 2019, filed 15 May 2019.